Skip to main content
. 2023 Nov 22;14:1273865. doi: 10.3389/fpsyt.2023.1273865

Table 3.

Correlations between scores on various questionnaires computed separately for addition patients (below the diagonal) and non-clinical control (above the diagonal).

(1) (2) (3) (4) (5) (6) (7) (8) (9)
MATE 2.1 severity of problem
(1) Level of craving for substance 0.27 0.24 −0.10 −0.02 0.39* 0.32 0.37* 0.29
(2) Substance use-related social problems 0.63*** 0.48** −0.27 −0.22 0.28 0.20 0.11 0.42*
(3) Substance use-related other problems 0.61*** 0.69*** −0.20 −0.05 0.30 0.25 0.30 0.22
MHQoL
(4) Quality of life −0.69*** −0.47** −0.55** 0.76*** −0.51** −0.44* −0.45** −0.38*
(5) Overall psychological wellbeing −0.53** −0.53** −0.64*** 0.80*** −0.36* −0.35* −0.24 −0.28
HQ-25
(6) Total score 0.65*** 0.58** 0.62*** −0.84*** −0.79*** 0.94*** 0.80*** 0.70***
(7) Socialization problems 0.67*** 0.56** 0.59*** −0.87*** −0.78*** 0.97*** 0.71*** 0.50***
(8) Isolation 0.60*** 0.52** 0.56** −0.79*** −0.72*** 0.97*** 0.96*** 0.30
(9) Lack of emotional support 0.51** 0.56** 0.58** −0.58** −0.68*** 0.80*** 0.66*** 0.68***

n = 31 for addiction patients, n = 34 for clinical controls. MATE 2.1, Measurement in the Addictions for Triage and Evaluation, version 2.1; MHQoL, Mental Health Quality of Life questionnaire. HQ-25 = 25-item Hikikomori Questionnaire. *** p <0.001, ** p <0.01, * p <0.05.